Fig. 8: GMT₅₀ from each study with minimum and maximum dilution titer also shown.

a post COVID-19-BA.1/Vac against WA-1, b post COVID-19-BA.1/Vac against Omicron BA.1, c post COVID-19 BA.1/Vac against Omicron BA.2, d post COVID-19 BA.1/Vac against BA.4/5. Source data are provided as a Source Data file.